Ovid Therapeutics Inc.OVIDNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank9
3Y CAGR-33.6%
5Y CAGR-28.8%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-33.6%/yr
vs +5.3%/yr prior
5Y CAGR
-28.8%/yr
Recent deceleration
Acceleration
-38.9pp
Decelerating
Percentile
P9
Near historical low
vs 5Y Ago
0.2x
Contraction
Streak
4 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $13.15M | -50.0% |
| 2024 | $26.30M | -2.7% |
| 2023 | $27.04M | -39.7% |
| 2022 | $44.87M | -76.1% |
| 2021 | $187.80M | +160.7% |
| 2020 | $72.03M | +71.9% |
| 2019 | $41.90M | +14.8% |
| 2018 | $36.49M | -58.1% |
| 2017 | $87.13M | +67.7% |
| 2016 | $51.94M | - |